As per Triton’s research report, the global surgical site infection control market acquired $4389.4 million in 2020. It is further predicted to register growth at a CAGR of 5.95% by 2028.
A recent study by Triton Market Research titled ‘Global Surgical Site Infection Control Market’ entails the Global Analysis and Forecasts by Type of Infection (Superficial Incisional SSI, Organ Or Space SSI, Deep Incisional SSI), Procedure (Microvascular, Laparoscopy, Cardiovascular, Obstetrics and Gynecology, Plastic & Reconstructive Surgery, Neurosurgery, Wound Closure, Thoracic Surgery, Urology, Orthopedic Surgery, Other Procedures), Product (Disinfectants [Skin Disinfectants, Hand Disinfectants], Manual Reprocessors Solution, Medical Nonwovens, Skin Preparation Solution, Surgical Drapes, Surgical Gloves, Surgical Scrubs, Hair Clippers, Surgical Irrigation, Other Products), Industrial Vertical (Hospitals, Ambulatory Surgical Centers), and by Geography (Middle East and Africa, Asia-Pacific, Europe, Latin America, North America).
Infection that occurs in a body part after surgery is termed as surgical site infection. The market for surgical site infection control is mainly motivated by the rising hospital-acquired infections, along with a surging number of surgical procedures.
Request Free Sample of the Global Surgical Site Infection Control Market Report @ https://www.tritonmarketresearch.com/reports/surgical-site-infection-control-market#request-free-sample
Triton’s research report denotes that the global surgical site infection control market is expected to advance at a CAGR of 5.95% during the forecast years 2021-2028. It is anticipated to attain revenue worth $6969.5 million by 2028.
Factors such as the growing aging population, paired with the enactment of best infection prevention and control practices, are driving the progress of the surgical site infection control market globally. The population worldwide is aging rapidly, owing to the significant rise in life expectancy. This growth in the aging population creates various healthcare challenges, resulting in the high occurrences of chronic conditions. Hence, the rising aging population drives the studied market’s progress. However, lack of infection control programs and surging use of outpatient procedures, are aspects obstructing the overall development of the surgical site infection control market.
The surgical site infection control market is segmented into a type of infection, procedure, product, and industrial vertical. Based on the type of infection, the market is divided into superficial incisional SSI, organ or space SSI, and deep incisional SSI. In terms of procedure, it is subdivided into microvascular, laparoscopy, cardiovascular, obstetrics and gynecology, plastic & reconstructive surgery, neurosurgery, wound closure, thoracic surgery, urology, orthopedic surgery, and other procedures.
Further, the product section is divided into disinfectants, manual reprocessors solution, medical nonwovens, skin preparation solution, surgical drapes, surgical gloves, surgical scrubs, hair clippers, surgical irrigation, and other products. Here, disinfectants are further branched into skin disinfectants and hand disinfectants. Lastly, the industrial vertical is bifurcated into hospitals and ambulatory surgical centers.
Geographically, North America is the largest market for surgical site infection control market. In the United States, SSI prevention is becoming extremely important as the number of surgeries continues to grow. This has resulted in the Centers for Disease Control and Prevention to use a web-based surveillance system to trace surgical site infections. Moreover, it permits hospitals, dialysis centers and other medical facilities to report infection rates among the patients. This rise in preventive measures to curb SSIs is anticipated to augment the surgical site infection control market’s growth across the region.
Pacon Manufacturing Corporation, Stryker Corporation, American Polyfilm, Getinge AB, Belimed AG, Lac-Mac, Gama Healthcare, Becton Dickinson and Company (BD), Kimberly Clark, Sotera Health LLC, Steris Corporation, Biomerieux SA, Ansell Ltd, 3M Company, and Johnson & Johnson are renowned companies engaged in the market.
Purchase this Report @ https://www.tritonmarketresearch.com/reports/surgical-site-infection-control-market#purchase-option
Question & Answer: Surgical Site Infection Control Market
Question 1: What major factors are driving the progress of the surgical site infection control market?
Answer: Factors such as the growing aging population, paired with the enactment of best infection prevention and control practices, are driving the progress of the surgical site infection control market globally.
The population worldwide is aging rapidly, owing to the significant rise in life expectancy. This growth in the aging population creates various healthcare challenges, resulting in the high occurrences of chronic conditions. Hence, the rising aging population drives the studied market’s progress.
Question 2: What aspects are obstructing the overall development of the surgical site infection control market?
Answer: The lack of infection control programs and surging use of outpatient procedures, are aspects obstructing the overall development of the surgical site infection control market.
Question 3: Which region is largest in the surgical site infection control market?
Answer: Geographically, North America is the largest market for surgical site infection control market. In the United States, SSI prevention is becoming extremely important as the number of surgeries continues to grow. This has resulted in the Centers for Disease Control and Prevention to use a web-based surveillance system to trace surgical site infections. Moreover, it permits hospitals, dialysis centers and other medical facilities to report infection rates among the patients. This rise in preventive measures to curb SSIs is anticipated to augment the surgical site infection control market’s growth across the region.
Question 4: Which are the renowned companies engaged in the surgical site infection control market?
Answer: Pacon Manufacturing Corporation, Stryker Corporation, American Polyfilm, Getinge AB, Belimed AG, Lac-Mac, Gama Healthcare, Becton Dickinson and Company (BD), Kimberly Clark, Sotera Health LLC, Steris Corporation, Biomerieux SA, Ansell Ltd, 3M Company, and Johnson & Johnson are renowned companies engaged in the market.
Related Report:
Global Pharmaceutical Filtration Market
The global pharmaceutical filtration market is probable to develop at a CAGR of 8.56% during the forecast period of 2021-2028, while gaining revenue worth $39947.0 million by 2028.
In the pharmaceutical sector, filtration is among the crucial processes undertaken to uphold the sterility of the products. Moreover, pharmaceutical filters are utilized at multiple manufacturing stages in the industry.
The surge in manufacturing of large molecule and biologics and rising healthcare spending, are driving the pharmaceutical filtration market on a growth path. Additionally, the increasing advancements in the biopharmaceutical industry is another factor opening several opportunities for the studied market’s progression.
However, the surging expectations by customers for high-quality drugs and the dearth of trained professionals in underdeveloped countries is limiting the studied market’s growth during the considered years.
Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/